Use of depo-provera in teens.
Currently, depot-medroxyprogesterone acetate is the only contraceptive injection available in the United States. Its use was approved by the U.S. Food and Drug Administration in October 1992. This article describes the mechanisms of action, advantages, disadvantages, and contraindications of this very effective contraceptive agent. In addition, the initial workup, the treatment, and the follow-up of the teen receiving depot-medroxyprogesterone acetate are presented.
Khoiny
F E
FE
D000293:Adolescent; D000359:Aftercare; D003271:Contraceptive Agents, Female / Q000627:therapeutic use*; D005193:Family Planning Services / Q000379:methods*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D011247:Pregnancy; D011253:Pregnancy in Adolescence
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate